Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

102P - Comparison of clinical characteristics and prognosis of incidentally detected and screening detected lung cancers

Date

03 Apr 2022

Session

Poster Display session

Topics

Tumour Site

Thoracic Malignancies

Presenters

Sungmin Zo

Citation

Annals of Oncology (2022) 33 (suppl_2): S79-S80. 10.1016/annonc/annonc859

Authors

S. Zo1, S.H. Shin2, B. Jeong2, K. Lee2, H. Kim2, O.J. Kwon2, S. Um2

Author affiliations

  • 1 Samsung Medical Center (SMC), Seoul/US
  • 2 Samsung Medical Center (SMC), Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 102P

Background

With the increasing use of the computed tomography (CT) scans, the clinicians more commonly encounter incidentally detected pulmonary nodules, parts of which are finally diagnosed as primary lung cancer during follow-up. The clinical characteristics of incidentally detected lung cancers (IDLCs) have not been well known in South Korea. In this study, we compared the clinical characteristics and prognosis of IDLC and screening detected lung cancer (SDLC).

Methods

This retrospective study included the subjects with pulmonary nodules (<3cm) at the baseline CT scans, which were pathologically confirmed as primary lung cancer in year 2015. The study population was classified as IDLC and SDLC according to the setting of the first pulmonary nodule detection. The symptomatic subjects at the time of the pulmonary nodule detection were excluded. Clinicoradiologic characteristics and overall survival (OS) rates were compared between the IDLC and SDLC groups.

Results

Among 553 study subjects, 209 (37.8%) IDLCs and 344 (62.2%) SDLCs were identified. IDLCs were most commonly discovered by the surveillance of other malignancy (36.4%) followed by the evaluation of benign diseases (32.1%). The IDLC group was older and had more smokers compared with the SDLC group. Adenocarcinomas were more commonly detected in the SDLC group (84.6%) than in the ILDC group (78.0%, P<0.001). The rates of pulmonary resection in the IDLC and SDLC groups were 86.1% and 87.8%, respectively (P=0.662). The 5-year OS rates of the IDLC group (80.9%) was similar to that of the SDLC group (84.9%, P=0.150).

Conclusions

Among non-symptomatic lung cancer patients, the proportion of IDLC was about 38% in our cohort. The IDLC group was associated with old age, smokers, history of other malignancy, and non-adenocarcinoma histology. However, the prognosis of the IDLC group was not inferior to the SDLC group.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.